Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Gross Profit Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual gross profit in 2023 was 464.3 Million BRL , down -30.48% from previous year.
Blau Farmacêutica S.A.'s latest quarterly gross profit in 2024 Q2 was 165.04 Million BRL , up 48.18% from previous quarter.
Blau Farmacêutica S.A. reported a annual gross profit of 667.87 Million BRL in annual gross profit 2022, up 0.29% from previous year.
Blau Farmacêutica S.A. reported a annual gross profit of 665.93 Million BRL in annual gross profit 2021, up 19.78% from previous year.
Blau Farmacêutica S.A. reported a quarterly gross profit of 111.38 Million BRL for 2024 Q1, up 0.1% from previous quarter.
Blau Farmacêutica S.A. reported a quarterly gross profit of 111.22 Million BRL for 2023 Q3, down -26.64% from previous quarter.

Annual Gross Profit Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Gross Profit of Blau Farmacêutica S.A. (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	464.3 Million BRL	-30.48%
2022	667.87 Million BRL	0.29%
2021	665.93 Million BRL	19.78%
2020	555.96 Million BRL	29.27%
2019	430.06 Million BRL	27.14%
2018	338.25 Million BRL	20.62%
2017	280.43 Million BRL	56.35%
2016	179.36 Million BRL	11.93%
2015	160.25 Million BRL	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	165.04 Million BRL	48.18%
2024 Q1	111.38 Million BRL	0.1%
2023 Q3	111.22 Million BRL	-26.64%
2023 Q1	107.35 Million BRL	-33.68%
2023 Q2	151.61 Million BRL	41.23%
2023 Q4	111.27 Million BRL	0.04%
2023 FY	464.3 Million BRL	-30.48%
2022 FY	667.87 Million BRL	0.29%
2022 Q4	161.87 Million BRL	-9.0%
2022 Q3	177.88 Million BRL	6.75%
2022 Q2	166.63 Million BRL	3.19%
2022 Q1	161.48 Million BRL	10.13%
2021 Q4	146.62 Million BRL	-4.75%
2021 Q1	170.88 Million BRL	6.49%
2021 Q3	153.93 Million BRL	-20.86%
2021 Q2	194.49 Million BRL	13.82%
2021 FY	665.93 Million BRL	19.78%
2020 Q2	144.86 Million BRL	44.38%
2020 FY	555.96 Million BRL	29.27%
2020 Q4	160.46 Million BRL	6.76%
2020 Q3	150.3 Million BRL	3.75%
2020 Q1	100.33 Million BRL	-3.63%
2019 Q3	119.43 Million BRL	-6.96%
2019 Q2	128.36 Million BRL	64.23%
2019 Q1	78.16 Million BRL	-24.73%
2019 FY	430.06 Million BRL	27.14%
2019 Q4	104.1 Million BRL	-12.83%
2018 Q2	66.04 Million BRL	-1.54%
2018 FY	338.25 Million BRL	20.62%
2018 Q4	103.84 Million BRL	2.53%
2018 Q3	101.28 Million BRL	53.35%
2018 Q1	67.08 Million BRL	0.0%
2017 FY	280.43 Million BRL	56.35%
2016 FY	179.36 Million BRL	11.93%
2015 FY	160.25 Million BRL	0.0%

Peer Gross Profit Comparison of Blau Farmacêutica S.A.

Name	Gross Profit	Gross Profit Difference
Hypera S.A.	4.99 Billion BRL	90.706%